OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa
8:16a ET March 1, 2013 (Business Wire) OPKO Health, Inc. (NYSE: OPK) announced that a study published online in Clinical Chemistry, and to be included in the April 2013 print issue, describes the application of OPKO's point-of-care system to mobile diagnostics, a major advance towards providing people in resource poor settings with laboratory-quality diagnostic services and directly integrating results with cloud-based patient records.
In collaboration with OPKO, Samuel Sia, associate Professor of Biomedical Engineering at Columbia Engineering and cofounder of Claros Diagnostics (now OPKO Diagnostics), has demonstrated that their lab-on-a-chip technology can be used not only to check a patient's infectious disease status anywhere in the world with just a finger #$%$, but also synchronize the results automatically and instantaneously with central health-care records. The device was field-tested in Rwanda by a collaborative team from Professor Sia's lab and ICAP at Columbia's Mailman School of Public Health.
According to Professor Sia, "We've built a handheld mobile device that can perform laboratory-quality testing in minutes on a finger stick drop of whole blood, and automatically synchronize the test results with patient health records across the globe using both cell phone and satellite networks." The core function of assay operation and real-time synchronization of diagnostic results with patient records in the cloud have all been incorporated onto a handheld mobile device and all powered by a battery.
Working with OPKO, ICAP, and the Ministry of Health, a local hospital, and two health clinics in Rwanda, Professor Sia and his team assessed the device's ability to perform HIV testing and then synchronized results in real time with the patients' electronic health records. They successfully tested serum, plasma, and whole blood samples,